# HR-HPV Multi-site Opportunistic Screening in Liaoning, China

> **NCT03178136** · — · UNKNOWN · sponsor: **Min Wang** · enrollment: 10000 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03178136
- **Lead sponsor:** Min Wang
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-19
- **Primary completion:** 2019-06
- **Final completion:** 2022-06
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2019-01-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03178136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03178136, "HR-HPV Multi-site Opportunistic Screening in Liaoning, China". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03178136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*